Mereo BioPharma Group
MREO · NASDAQ
$0.2951−$0.007 (−2.32%)TodayMarket closed ·
Prev close $0.3021
Who owns MREO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 6.6% of MREO’s shares.
- Rubric Capital Management LP1.9%
- 683 Capital Management LLC1.5%
- BofA Global Research (US)1.0%
- Defilade Capital Management, L.P.0.9%
- Next 6 largest institutions1.2%
- All other shareholders93.4%
| Holder | Shares | % of shares |
|---|---|---|
| Rubric Capital Management LP | 15.31M | 1.92% |
| 683 Capital Management LLC | 11.78M | 1.48% |
| BofA Global Research (US) | 8.20M | 1.03% |
| Defilade Capital Management, L.P. | 7.56M | 0.95% |
| Newtyn Management, LLC | 3.00M | 0.38% |
| Tejara Capital Ltd. | 2.04M | 0.26% |
| UBS Financial Services, Inc. | 1.45M | 0.18% |
| Two Sigma Investments, LP | 1.33M | 0.17% |
| EcoR1 Capital, LLC | 1.00M | 0.13% |
| Truvalue Asset Management Co., Ltd. | 992.10K | 0.12% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Truvalue Global Medical Biology Equity Seed Fund (QDII) | 992.10K | 0.12% |
| State Street SPDR S&P International Small Cap ETF | 136.82K | 0.02% |
| Blackstone Alternative Multi-Strategy Fund | 1.20K | 0.00% |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.68M
- Days to cover
- 1.25
- % of shares outstanding
- 0.34%
- Average daily volume
- 2.14M
- Change since last report
- −12.9%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.